Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san diego blog main
san diego top stories
5
×
biotech
national top stories
new york blog main
boston blog main
boston top stories
clinical trials
drugs
new york top stories
pfizer
san francisco blog main
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
san diego
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
achaogen
acorda therapeutics
What
drug
5
×
year
5
×
companies
disease
fda
medicines
new
therapeutics
therapies
ago
akcea
alnylam
alzheimer’s
amyloidosis
approval
approved
arguments
athena
attr
available
bacteria
battle
big
bio
biopharma
biotech
business
cancer
ceo
chief
class
commercialized
company
competitors
countouriotis
debilitating
decades
different
drugs
exited
Language
Current search:
drug
×
" san diego top stories "
×
year
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push